BG102014A - Carbapenem esters - Google Patents
Carbapenem estersInfo
- Publication number
- BG102014A BG102014A BG102014A BG10201497A BG102014A BG 102014 A BG102014 A BG 102014A BG 102014 A BG102014 A BG 102014A BG 10201497 A BG10201497 A BG 10201497A BG 102014 A BG102014 A BG 102014A
- Authority
- BG
- Bulgaria
- Prior art keywords
- carbapenem
- esters
- carbapenem esters
- methyl
- benzoyloxyemethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9508957.9A GB9508957D0 (en) | 1995-05-03 | 1995-05-03 | Novel compounds |
GBGB9508955.3A GB9508955D0 (en) | 1995-05-03 | 1995-05-03 | Novel compounds |
GBGB9508956.1A GB9508956D0 (en) | 1995-05-03 | 1995-05-03 | Novel compounds |
PCT/EP1996/001880 WO1996034868A1 (en) | 1995-05-03 | 1996-05-02 | Esters of carbapenems |
Publications (1)
Publication Number | Publication Date |
---|---|
BG102014A true BG102014A (en) | 1998-11-30 |
Family
ID=27267696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102014A BG102014A (en) | 1995-05-03 | 1997-11-03 | Carbapenem esters |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0823910A1 (xx) |
JP (1) | JPH11504910A (xx) |
KR (1) | KR19990008355A (xx) |
CN (1) | CN1185783A (xx) |
AR (1) | AR005416A1 (xx) |
AU (1) | AU5813996A (xx) |
BG (1) | BG102014A (xx) |
BR (1) | BR9608313A (xx) |
CA (1) | CA2217990A1 (xx) |
CZ (1) | CZ347597A3 (xx) |
EA (1) | EA199700293A1 (xx) |
HU (1) | HUP9801066A3 (xx) |
IL (1) | IL118092A0 (xx) |
MA (1) | MA23853A1 (xx) |
MX (1) | MX9708421A (xx) |
NO (1) | NO974994D0 (xx) |
OA (1) | OA10632A (xx) |
PE (1) | PE50697A1 (xx) |
PL (1) | PL323141A1 (xx) |
SK (1) | SK146497A3 (xx) |
TR (1) | TR199701286T1 (xx) |
WO (1) | WO1996034868A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2902659A1 (fr) | 2006-06-23 | 2007-12-28 | Pierre Fabre Medicament Sa | Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires |
WO2013157583A1 (ja) * | 2012-04-18 | 2013-10-24 | 大日本住友製薬株式会社 | 新規カルバペネム化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1593524A (en) * | 1976-11-19 | 1981-07-15 | Merck & Co Inc | 1-carba-2-penem-3-carboxylic acids |
CA1212105A (en) * | 1980-04-30 | 1986-09-30 | Shoji Ikeda | Ampicillin esters and production thereof |
AU7467194A (en) * | 1993-08-18 | 1995-03-14 | Sankyo Company Limited | Crystalline carbapenem derivatives |
WO1995011905A1 (en) * | 1993-10-29 | 1995-05-04 | Smithkline Beecham Plc | 2-(pyrazol-3-yl)carbapenem derivatives |
-
1996
- 1996-05-01 IL IL11809296A patent/IL118092A0/xx unknown
- 1996-05-02 WO PCT/EP1996/001880 patent/WO1996034868A1/en not_active Application Discontinuation
- 1996-05-02 MX MX9708421A patent/MX9708421A/es unknown
- 1996-05-02 EP EP96919678A patent/EP0823910A1/en not_active Withdrawn
- 1996-05-02 AU AU58139/96A patent/AU5813996A/en not_active Abandoned
- 1996-05-02 SK SK1464-97A patent/SK146497A3/sk unknown
- 1996-05-02 MA MA24218A patent/MA23853A1/fr unknown
- 1996-05-02 KR KR1019970707881A patent/KR19990008355A/ko not_active Application Discontinuation
- 1996-05-02 CN CN96194191A patent/CN1185783A/zh active Pending
- 1996-05-02 PL PL96323141A patent/PL323141A1/xx unknown
- 1996-05-02 TR TR97/01286T patent/TR199701286T1/xx unknown
- 1996-05-02 HU HU9801066A patent/HUP9801066A3/hu unknown
- 1996-05-02 CZ CZ973475A patent/CZ347597A3/cs unknown
- 1996-05-02 EA EA199700293A patent/EA199700293A1/ru unknown
- 1996-05-02 BR BR9608313A patent/BR9608313A/pt not_active Application Discontinuation
- 1996-05-02 JP JP8533020A patent/JPH11504910A/ja active Pending
- 1996-05-02 CA CA002217990A patent/CA2217990A1/en not_active Abandoned
- 1996-05-03 AR ARP960102434A patent/AR005416A1/es unknown
- 1996-05-03 PE PE1996000312A patent/PE50697A1/es not_active Application Discontinuation
-
1997
- 1997-10-30 NO NO974994A patent/NO974994D0/no not_active Application Discontinuation
- 1997-11-03 BG BG102014A patent/BG102014A/xx unknown
- 1997-11-03 OA OA70122A patent/OA10632A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PE50697A1 (es) | 1997-12-18 |
WO1996034868A1 (en) | 1996-11-07 |
EA199700293A1 (ru) | 1998-06-25 |
OA10632A (en) | 2002-09-16 |
MX9708421A (es) | 1998-02-28 |
MA23853A1 (fr) | 1996-12-31 |
BR9608313A (pt) | 1999-01-26 |
TR199701286T1 (xx) | 1998-02-21 |
PL323141A1 (en) | 1998-03-16 |
EP0823910A1 (en) | 1998-02-18 |
JPH11504910A (ja) | 1999-05-11 |
KR19990008355A (ko) | 1999-01-25 |
SK146497A3 (en) | 1998-05-06 |
NO974994L (no) | 1997-10-30 |
CN1185783A (zh) | 1998-06-24 |
AU5813996A (en) | 1996-11-21 |
NO974994D0 (no) | 1997-10-30 |
IL118092A0 (en) | 1996-09-12 |
HUP9801066A2 (hu) | 1998-08-28 |
CZ347597A3 (cs) | 1998-08-12 |
HUP9801066A3 (en) | 1999-01-28 |
AR005416A1 (es) | 1999-06-23 |
CA2217990A1 (en) | 1996-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5370096A (en) | Method of treating or preventing non-viral microbial infection | |
AU6529796A (en) | Biological agent compositions | |
AU6625896A (en) | Oxygen bandage | |
AU5362696A (en) | Compounds and methods for the dectection of t. cruzi infection | |
AU2663097A (en) | Compounds and methods for the selective treatment of cancer and bacterial infections | |
AU5860396A (en) | Substituted oxazoles for the treatment of inflammation | |
AU685029B2 (en) | Method of strengthening antibacterial action of antibiotics | |
AU5254696A (en) | Reduced toxicity compositions and methods for treating hiv infections | |
BG104117A (en) | Universally applicable blood plasma | |
FI960193A0 (fi) | Menetelmä mikro-organismien deaktivoimiseksi | |
AU3328693A (en) | Treatment of fungal infections | |
MX9708611A (es) | Compuestos de dialquiltiacumicina. | |
IL122942A0 (en) | Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them | |
AU3279093A (en) | Method for decreasing the allergenicity of psyllium seed husk by enzyme treatment | |
AU5758594A (en) | Treatment of viral infections | |
BG102014A (en) | Carbapenem esters | |
AU1192797A (en) | Oxidase, microorganisms producing the same and use of the same | |
NO973366L (no) | Fremgangsmåte for behandling av multippel sklerose | |
NZ332453A (en) | (1R,5S,6S)-6-[(1R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-[(3R)-3-methylaminomethylpyrrolidin-1-ylcarbonyl]pyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylic acid for the prevention or treatment of bacterial infections | |
FR2689518B1 (fr) | Microorganismes, procédé de préparation et utilisation. | |
WO1996026728A3 (en) | Use of moxonidine for the treatment of atherosclerosis | |
AU6352994A (en) | Flocculated microbial inoculants for delivery of agriculturally beneficial microorganisms | |
AU1593792A (en) | Treatment of mastitis | |
AU3215395A (en) | Carbapenem compounds, compositions and methods of treatment | |
ZA963471B (en) | Carbapenem esters useful in the treatment of bacterial infections |